Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole. Like all ...

The VanEck Pharmaceutical ETF provides diversified exposure to the world's largest pharmaceutical companies, focusing on 'big pharma' through a cap-weighted index. PPH tracks the MVIS US Listed ...

Diversify Outside the U.S. Heavyweights: Global healthcare ETFs like iShares Global Healthcare ETF (NYSE: MIXJ) provide exposure to pharma names outside the U.S., reducing risk from domestic tariff ...

A smart beta exchange traded fund, the State Street SPDR S&P Pharmaceuticals ETF (XPH) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”.

The current generation of deals, which is likely to involve AbbVie (NYSE: ABBV), Merck & Co Inc (NYSE: MRK), Bristol-Myers Squibb Co (NYSE: BMY), and Gilead Sciences Inc (NYSE: GILD), is focused on ...

We recently published 10 Most Popular Analyst Calls to Watch This Week. VanEck Pharmaceutical ETF (NASDAQ:PPH) is one of the trending stocks. Many analysts are picking healthcare stocks as indicators ...

It appears the pharmaceutical industry may avoid threatened tariffs. An exchange-traded fund (ETF) is a great way to invest in major drugmakers. Pharmaceutical stocks are having a moment. The S&P 500 ...

Learn how LABD delivers -3x daily biotech exposure, why it’s down 99.98% since inception, and when it fits short-term trades.